Primary isolation of Ehrlichia chaffeensis from patients with febrile illnesses: Clinical and molecular characteristics

Journal of Infectious Diseases

Volumn 181, Issue 3, 2000, Pages 1082-1088

  Standaert, Steven M ^a   Yu, Tina ^a   Scott, Margie A ^a   Childs, James E ^b   Paddock, Christopher D ^b   Nicholson, William L ^b   Singleton Jr , Joseph ^b   Blaser, Martin J ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; DISEASE TRANSMISSION; EHRLICHIA CHAFFEENSIS; FEVER; HUMAN; NONHUMAN; PRIORITY JOURNAL; RICKETTSIOSIS; TICK BORNE DISEASE;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; EHRLICHIA CHAFFEENSIS; EHRLICHIOSIS; FEMALE; FEVER; HUMANS; INFANT; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 0034030762     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315346     Document Type: Article

References (28)

1. 1. Maeda K, Markowitz N, Hawley RC, Ristic M. Cox D, McDade JE. Human infection with Ehrlichia canis, a leukocytic rickettsia. N Engl J Med 1987;316:853-6.
2. 2. Dawson JE, Anderson BE, Fishbein DB, et al. Isolation and characterization of an Ehrlichia sp. from a patient diagnosed with human ehrlichiosis. J Clin Microbiol 1991;29:2741-5.
3. 3. Dumler JS, Chen SM, Asanovich K, Trigiani E, Popov VL, Walker DH. Isolation and characterization of a new strain of Ehrlichia chaffeensis from a patient with near fatal monocytic ehrlichiosis. J Clin Microbiol 1995; 33:1704-11.
4. 4. Chen SM, Yu XJ, Popov VL, Westerman EL, Hamilton FG, Walker DH. Genetic and antigenic diversity of Ehrlichia chaffeensis: comparative analysis of a novel human strain from Oklahoma and previously isolated strains. J Infect Dis 1997;175:856-63.
5. 5. Paddock CD, Sumner JW, Shore GM, et al. Isolation and characterization of Ehrlichia chaffeensis strains from patients with fatal ehrlichiosis. J Clin Microbiol 1997;35:2496-502.
6. 6. Sumner JW, Childs JE, Paddock CD. Molecular cloning and characterization of the Ehrlichia chaffeensis variable length PCR target: an antigen-expressing gene that exhibits interstrain variation. J Clin Microbiol 1999; 37:1447-53.
7. 7. Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, et al. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis 1998;27:1314-7.
8. 8. Yu XJ, Crocquet-Valdes P, Walker DH. Cloning and sequencing of the gene for a 120-kDa immunodominant protein of Ehrlichia chaffeensis. Gene 1997;184:149-54.
9. 9. Yu XJ, Piesman JF, Olson JG, Walker DH. Short report: geographic distribution of different genetic types of Ehrlichia chaffeensis. Am J Trop Med Hyg 1997;56:679-80.
10. 10. Warner CK, Dawson JE. Genus- and species-level identification of Ehrlichia species by PCR and sequencing. In: Persing DH, ed. PCR protocols for emerging infectious diseases. Washington, DC: American Society for Microbiology Press, 1996:100-5.
11. 11. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Morb Mortal Wkly 1997;46(RR-10):1-55.
12. 12. Dean AG, Dean JA, Burton AH, Dicker RC. Epi Info, version 5: a word processing, database, and statistics program for epidemiology on microcomputers. Stone Mountain, GA: USD, 1990.
13. 13. Oster CN, Burke DS, Kenyon RH, Ascher MS, Harber P, Petersen CE Jr. Laboratory-acquired Rocky Mountain spotted fever. The hazard of aerosol transmission. N Engl J Med 1977;297:859-63.
14. 14. Goodman JL, Nelson C, Vitale B, et al. Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N Engl J Med 1996;334:209-15.
15. 15. Standaert SM, Dawson JE, Schaffner W, et al. Ehrlichiosis in a golf-oriented retirement community. N Engl J Med 1995;333:420-5.
16. 16. Everett ED, Evans KA, Henry RB, McDonald G. Human ehrlichiosis in adults after tick exposure. Diagnosis using polymerase chain reaction. Ann Intern Med 1994;120:730-5.
17. 17. Walker DH, Dumler JS. Emergence of the ehrlichioses as human health problems. Emerg Infect Dis 1996;2:18-29.
18. 18. Anderson BE, Sims KG, Olson JG. et al. Amblyomma americanum: a potential vector of human ehrlichiosis. Am J Trop Med Hyg 1993;49:239-44.
19. 19. Hair JA, Bowman JL. Behavioral ecology of Amblyomma americanum. In: Sauer JR, Hair JA, eds. Morphology, physiology, and behavioral biology of ticks. Chichester, UK: Ellis Horwood, 1986:406-27.
20. 20. Sonenshine DE. Ecology of non-nidiculous ticks. In: Biology of ticks. Vol 2. New York: Oxford University Press, 1993:3-65.
21. 21. Standaert SM, Clough LA, Schaffner W, Adams JS, Neuzil KM. Neurologic manifestations of human monocytic ehrlichiosis. Infect Dis Clin Pract 1998;7:358-62.
22. 22. Ratnasamy N, Everett ED, Roland WE, McDonald G, Caldwell CW. Central nervous system manifestations of human ehrlichiosis. Clin Infect Dis 1996;23:314-9.
23. 23. Dunn BE, Monson TP, Dumler JS, et al. Identification of Ehrlichia chaffeensis morulae in cerebrospinal fluid mononuclear cells. J Clin Microbiol 1992;30:2207-10.
24. 24. Anderson BE, McDonald GA, Jones DC, Regnery RL. A protective protein antigen of Rickettsia rickettsii has tandemly repeated, near identical sequences. Infect Immun 1990;58:2760-9.
25. 25. Walker DH, Feng HM, Saada JI, et al. Comparative antigenic analysis of spotted fever group rickettsiae from Israel and other closely related organisms. Am J Trop Med Hyg 1995;52:569-76.
26. 26. Li H, Walker DH. rOmpA is a critical protein for the adhesion of Rickettsia rickettsii to host cells. Microb Pathog 1998;24:289-98.
27. 27. Uchiyama T. Role of major surface antigens of Rickettsia japonica in the attachment to host cells. In: Raoult D, Brouqui P, eds: Rickettsiae and rickettsial diseases at the turn of the third millennium. Paris: Elsevier, 1999:182-8.
28. 28. Blaser MJ. Bacteria and diseases of unknown cause. Ann Intern Med 1994;121:144-5.